Marijuana use associated with higher stroke, bleeding risks after heart procedures

Study finds some complications, but no significant difference in risk of death.

8:02 AM

Author | Haley Otman

hospital bed drawn in blue ink with badge on bottom right saying lab note in yellow
Michigan Medicine

A new publication reports people who use marijuana were more likely to experience complications after a common minimally invasive procedure to restore blood flow through the arteries.

Nearly 4,000 of the more than 100,000 people who underwent percutaneous coronary intervention in Michigan between 2013 and 2016 reported having used marijuana. Those patients had a significantly higher risk of bleeding and cerebrovascular accidents like a stroke. However, risk of death was not significantly different between the two groups.

"Clinicians and patients should be aware of increased risk of post-PCI complications in these patients," the study authors wrote.

In addition, researchers found that patients who reported using marijuana had a lower risk of acute kidney injury.

"Although people who smoke marijuana may be at higher risk for complications such as stroke and post-PCI bleeding, this should not deter patients who use or have used marijuana from pursuing potentially life-saving PCI procedures," said lead author Sang Gune (Kyle) Yoo, M.D., a resident physician at University of Michigan Health, in an American Heart Association story.

"With the increasing use of marijuana and cannabis products, continued research is desperately needed to understand the health effects of marijuana use so that we can have well informed conversations with our patients," said study author Devraj Sukul, M.D., an interventional cardiologist at the University of Michigan Health Frankel Cardiovascular Center.

The study comes from the Michigan Cardiovascular Consortium, known as BMC2, which is housed at University of Michigan Health and includes collaborators from institutions across the state that participate in the quality improvement initiative.

Yoo previously presented the findings at the 2020 American Heart Association Scientific Sessions.

The researchers were funded in part by the National Institutes of Health, although this content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, nor of Blue Cross Blue Shield of Michigan, which funds the BMC2 coordinating center.

Paper cited: "Marijuana Use and In-Hospital Outcomes After Percutaneous Coronary Intervention in Michigan, United States," JACC: Cardiovascular Interventions. DOI: 10.1016/j.jcin.2021.06.036


More Articles About:

Lab Notes Interventional cardiology Heart disease Cardiovascular: Treatment & Surgery Cardiovascular: Diagnostics & Procedures
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
A smartphone displaying a red heart with a white EKG line on its screen, set against a teal background.
Health Lab

Mobile health app improves heart failure medication use, dosing after hospitalization

A U-M-led trial found a mobile app improved use and dosing of recommended heart failure medications during the 90 days following a hospital discharge.
Boy in white t-shirt, just chin showing, with hands holding a stethoscope on his chest.
Health Lab

Distance, insurance, social factors may hinder access to lifesaving heart monitoring for children

New research suggests that social, economic and geographic factors may influence whether patients who undergo the Fontan surgery for complex congenital heart disease receive the recommended lifelong cardiac monitoring.
Three people in a bar watch a television displaying a sports logo and a person smiling. Shelves with bottles and a counter with glasses are visible.
Health Lab

Jalen Hurts’ blood clot diagnosis: doctors answer common questions

After Jalen Hurts’ blood clot diagnosis, Michigan Medicine experts explain clot risks, treatment and returning safely to sports.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.